183 related articles for article (PubMed ID: 2468054)
1. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
[TBL] [Abstract][Full Text] [Related]
2. Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction.
Lynch JJ; Uprichard AC; Frye JW; Driscoll EM; Kitzen JM; Lucchesi BR
J Cardiovasc Pharmacol; 1989 Oct; 14(4):585-97. PubMed ID: 2478772
[TBL] [Abstract][Full Text] [Related]
3. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
[TBL] [Abstract][Full Text] [Related]
4. Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death.
Kitzen JM; Lynch JJ; Uprichard AC; Venkatesh N; Lucchesi BR
Pharmacology; 1988; 37(3):171-86. PubMed ID: 3227051
[TBL] [Abstract][Full Text] [Related]
5. A model of chronic ischemic arrhythmias: the relation between electrically inducible ventricular tachycardia, ventricular fibrillation threshold and myocardial infarct size.
Gang ES; Bigger JT; Livelli FD
Am J Cardiol; 1982 Sep; 50(3):469-77. PubMed ID: 7113930
[TBL] [Abstract][Full Text] [Related]
6. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.
Asanoi H; Ishizaka S; Kameyama T; Ishise H; Sasayama S
J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757
[TBL] [Abstract][Full Text] [Related]
7. Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.
Duncker DJ; Hartog JM; Levinsky L; Verdouw PD
Br J Pharmacol; 1987 Jul; 91(3):609-15. PubMed ID: 3607369
[TBL] [Abstract][Full Text] [Related]
8. Promotion of ventricular tachycardia induction by procainamide in dogs with inducible ventricular fibrillation late after myocardial infarction.
Hunt GB; Ross DL
Pacing Clin Electrophysiol; 1990 Jul; 13(7):882-9. PubMed ID: 1695745
[TBL] [Abstract][Full Text] [Related]
9. Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death.
Kou WH; Nelson SD; Lynch JJ; Montgomery DG; DiCarlo L; Lucchesi BR
J Am Coll Cardiol; 1987 Feb; 9(2):359-65. PubMed ID: 3100599
[TBL] [Abstract][Full Text] [Related]
10. Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model.
Wilber DJ; Lynch JJ; Montgomery D; Lucchesi BR
Am Heart J; 1985 Jan; 109(1):8-18. PubMed ID: 3966335
[TBL] [Abstract][Full Text] [Related]
11. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Black SC; Butterfield JL; Lucchesi BR
J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
[TBL] [Abstract][Full Text] [Related]
12. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S
Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887
[TBL] [Abstract][Full Text] [Related]
13. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
Patterson E; Amalfitano DJ; Lucchesi BR
J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
[TBL] [Abstract][Full Text] [Related]
14. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A
J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
[TBL] [Abstract][Full Text] [Related]
15. Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium.
Takahashi R; Shimazaki Y; Endoh M
J Pharmacol Exp Ther; 2001 Sep; 298(3):1060-6. PubMed ID: 11504803
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of three anesthetic agents on induction of ventricular tachycardia in a canine model of myocardial infarction.
Hunt GB; Ross DL
Circulation; 1988 Jul; 78(1):221-6. PubMed ID: 3383405
[TBL] [Abstract][Full Text] [Related]
17. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic profile of the cardiotonic agent pimobendan.
van Meel JC; Diederen W
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
[TBL] [Abstract][Full Text] [Related]
20. Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
Joho S; Asanoi H; Ishizaka S; Kameyama T; Inoue H
J Card Fail; 2002 Dec; 8(6):423-30. PubMed ID: 12528096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
